Generation of interleukin-17 receptor-like protein (IL-17RL) in prostate by alternative splicing of RNA

Dominik R Haudenschild, Shane B. Curtiss, Timothy A. Moseley, A Hari Reddi

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

BACKGROUND. Interleukin-17 receptor-like protein (IL-17RL) expressed in prostate tissues changes with advanced cancers due to extensive alternative splicing, which affects the final protein. Predominant IL-17RL splice isoform variants have not been identified, hindering functional studies. METHODS. A cDNA library of IL-17RL transcripts was arrayed onto nylon membranes. Individual transcript exon structures were determined by successively probing membranes with exon-specific oligonucleotides. The most common variants were transiently over-expressed in 293T cells. RESULTS. We detected >90 different IL-17RL isoforms. Three most abundant isoforms account for approximately half the total transcripts; the full-length variant just over 11%. Surprisingly, most alternative splicing does not alter the reading frame of the full-length molecule; therefore, resulting proteins vary mostly in N-terminal domains. CONCLUSIONS. IL-17RL exists as multiple isoforms due to extensive alternative splicing. We identified the most abundant splices in prostate tissue and established a technique to investigate changes in RNA IL-17RL splicing that occur in advanced cancers.

Original languageEnglish (US)
Pages (from-to)1268-1274
Number of pages7
JournalProstate
Volume66
Issue number12
DOIs
StatePublished - Sep 1 2006

Fingerprint

Interleukin-17 Receptors
Alternative Splicing
Prostate
Protein Isoforms
Proteins
Exons
Protein Splicing
Reading Frames
Membranes
HEK293 Cells
Nylons
Gene Library
Oligonucleotides
Neoplasms
RNA

Keywords

  • Alternative splicing
  • Gleason grade
  • IL-17RC
  • IL-17RL
  • Prostate cancer

ASJC Scopus subject areas

  • Urology

Cite this

Generation of interleukin-17 receptor-like protein (IL-17RL) in prostate by alternative splicing of RNA. / Haudenschild, Dominik R; Curtiss, Shane B.; Moseley, Timothy A.; Reddi, A Hari.

In: Prostate, Vol. 66, No. 12, 01.09.2006, p. 1268-1274.

Research output: Contribution to journalArticle

@article{28f17069cd7443a795dfd5de8a12072f,
title = "Generation of interleukin-17 receptor-like protein (IL-17RL) in prostate by alternative splicing of RNA",
abstract = "BACKGROUND. Interleukin-17 receptor-like protein (IL-17RL) expressed in prostate tissues changes with advanced cancers due to extensive alternative splicing, which affects the final protein. Predominant IL-17RL splice isoform variants have not been identified, hindering functional studies. METHODS. A cDNA library of IL-17RL transcripts was arrayed onto nylon membranes. Individual transcript exon structures were determined by successively probing membranes with exon-specific oligonucleotides. The most common variants were transiently over-expressed in 293T cells. RESULTS. We detected >90 different IL-17RL isoforms. Three most abundant isoforms account for approximately half the total transcripts; the full-length variant just over 11{\%}. Surprisingly, most alternative splicing does not alter the reading frame of the full-length molecule; therefore, resulting proteins vary mostly in N-terminal domains. CONCLUSIONS. IL-17RL exists as multiple isoforms due to extensive alternative splicing. We identified the most abundant splices in prostate tissue and established a technique to investigate changes in RNA IL-17RL splicing that occur in advanced cancers.",
keywords = "Alternative splicing, Gleason grade, IL-17RC, IL-17RL, Prostate cancer",
author = "Haudenschild, {Dominik R} and Curtiss, {Shane B.} and Moseley, {Timothy A.} and Reddi, {A Hari}",
year = "2006",
month = "9",
day = "1",
doi = "10.1002/pros.20422",
language = "English (US)",
volume = "66",
pages = "1268--1274",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Generation of interleukin-17 receptor-like protein (IL-17RL) in prostate by alternative splicing of RNA

AU - Haudenschild, Dominik R

AU - Curtiss, Shane B.

AU - Moseley, Timothy A.

AU - Reddi, A Hari

PY - 2006/9/1

Y1 - 2006/9/1

N2 - BACKGROUND. Interleukin-17 receptor-like protein (IL-17RL) expressed in prostate tissues changes with advanced cancers due to extensive alternative splicing, which affects the final protein. Predominant IL-17RL splice isoform variants have not been identified, hindering functional studies. METHODS. A cDNA library of IL-17RL transcripts was arrayed onto nylon membranes. Individual transcript exon structures were determined by successively probing membranes with exon-specific oligonucleotides. The most common variants were transiently over-expressed in 293T cells. RESULTS. We detected >90 different IL-17RL isoforms. Three most abundant isoforms account for approximately half the total transcripts; the full-length variant just over 11%. Surprisingly, most alternative splicing does not alter the reading frame of the full-length molecule; therefore, resulting proteins vary mostly in N-terminal domains. CONCLUSIONS. IL-17RL exists as multiple isoforms due to extensive alternative splicing. We identified the most abundant splices in prostate tissue and established a technique to investigate changes in RNA IL-17RL splicing that occur in advanced cancers.

AB - BACKGROUND. Interleukin-17 receptor-like protein (IL-17RL) expressed in prostate tissues changes with advanced cancers due to extensive alternative splicing, which affects the final protein. Predominant IL-17RL splice isoform variants have not been identified, hindering functional studies. METHODS. A cDNA library of IL-17RL transcripts was arrayed onto nylon membranes. Individual transcript exon structures were determined by successively probing membranes with exon-specific oligonucleotides. The most common variants were transiently over-expressed in 293T cells. RESULTS. We detected >90 different IL-17RL isoforms. Three most abundant isoforms account for approximately half the total transcripts; the full-length variant just over 11%. Surprisingly, most alternative splicing does not alter the reading frame of the full-length molecule; therefore, resulting proteins vary mostly in N-terminal domains. CONCLUSIONS. IL-17RL exists as multiple isoforms due to extensive alternative splicing. We identified the most abundant splices in prostate tissue and established a technique to investigate changes in RNA IL-17RL splicing that occur in advanced cancers.

KW - Alternative splicing

KW - Gleason grade

KW - IL-17RC

KW - IL-17RL

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=33748337902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748337902&partnerID=8YFLogxK

U2 - 10.1002/pros.20422

DO - 10.1002/pros.20422

M3 - Article

VL - 66

SP - 1268

EP - 1274

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 12

ER -